Kenneth Hoberman - Director at Tg Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
TGTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kenneth Hoberman since 11/21/2023

Holdings reported by Kenneth Hoberman for Tg Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 265K $4.22M $15.94 Jun 19, 2024 Direct

Transactions reported by Kenneth Hoberman for Tg Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.